Overview
ILMN market data
Price History
ILMN price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ILMN. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
New AI ETF Bets on Healthcare's $9 Trillion OpportunityBenzinga · Jul 24, 2026, 7:08 PM
Blood Transfusion Diagnostics Market Size to Hit USD 8.67 Billion by 2035 as Automated Testing and AI-Driven Blood Safety Solutions Accelerate Growth | SNS InsiderGlobenewswire Inc · Jul 24, 2026, 2:15 PM
Leerink Partners Maintains Outperform on Illumina, Raises Price Target to $210Benzinga · Jul 17, 2026, 6:12 PM
Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption AccelerateGlobenewswire Inc · Jul 17, 2026, 11:15 AM
Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ DealsGlobenewswire Inc · Jul 17, 2026, 11:15 AM
Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $190Benzinga · Jul 14, 2026, 11:56 AM
Evercore ISI Group Maintains Outperform on Illumina, Raises Price Target to $200Benzinga · Jul 6, 2026, 4:20 PM
Environmental DNA Market Set to Surge to USD 5.61 Billion by 2031 with 10.2% CAGRGlobenewswire Inc · Jul 6, 2026, 11:00 AM
Molecular Biology Enzymes, Reagents and Kits Market Size Worth USD 70.85 Billion by 2035 | SNS InsiderGlobenewswire Inc · Jul 3, 2026, 11:15 AM
Piper Sandler Maintains Overweight on Illumina, Raises Price Target to $200Benzinga · Jul 1, 2026, 12:00 PM